<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: liver cells</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Antifibrotic effects of green tea</title>
   	 <description>Several studies have shown that lipid peroxidation stimulates collagen production in fibroblasts and hepatic stellate cells (HSC), and plays an important role in the development of liver fibrosis. Hepatoprotective effects of green tea against carbon tetrachloride, cholestasis and alcohol induced liver fibrosis were reported in many studies. However, the hepatoprotective effect of green tea in dimethylnitrosamine (DMN)-induced models has not been studied.</description>
     <link>http://www.physorg.com/news177760503.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 18 Nov 2009 10:20:18 EST</pubDate>
	 <guid isPermaLink="false">news177760503</guid>
</item>
<item>
     <title>Transplanted Liver Cells Hold Hope for Treating Inherited Diseases</title>
   	 <description>(PhysOrg.com) -- Mike Gibson, chair of the Department of Biological Sciences at Michigan Technological University, has spent most of his professional life trying to better understand genetic metabolic disorders that arise in children. With that knowledge, he is working to develop treatments in mice--including liver-cell transplants--that could one day be used to treat a variety of liver-based illnesses in people.</description>
     <link>http://www.physorg.com/news174291354.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 09 Oct 2009 07:40:01 EST</pubDate>
	 <guid isPermaLink="false">news174291354</guid>
</item>
<item>
     <title>A breath of fresh air could improve drug toxicity screening</title>
   	 <description>A team led by Massachusetts General Hospital (MGH) researchers has developed an innovative way to culture liver cells for drug toxicity screening.  In a report to be published in Proceedings of the National Academy of Sciences that has been released online, the investigators describe how liver cells grown in a high-oxygen environment and in a culture medium free of animal-derived serum quickly begin to function as they do within the liver.</description>
     <link>http://www.physorg.com/news171127242.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 02 Sep 2009 17:10:04 EST</pubDate>
	 <guid isPermaLink="false">news171127242</guid>
</item>
<item>
     <title>New strategy for inhibiting virus replication</title>
   	 <description>Viruses need living cells for replication and production of virus progeny. Thus far, antiviral therapy primarily targets viral factors but often induces therapy resistance. New improved therapies attempt to targets cellular factors that are essential for viral replication.</description>
     <link>http://www.physorg.com/news169473882.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 14 Aug 2009 13:20:01 EST</pubDate>
	 <guid isPermaLink="false">news169473882</guid>
</item>
<item>
     <title>New steps forward in cell reprogramming</title>
   	 <description>(PhysOrg.com) -- Harvard Stem Cell Institute (HSCI) researchers at Massachusetts General Hospital (MGH) have substantially improved the odds of successfully reprogramming differentiated cells into induced pluripotent stem cells (iPS) by blocking the activity of the gene that instructs the cells to stop dividing.</description>
     <link>http://www.physorg.com/news169136061.html</link>
	 <category>Biology</category>
	 <pubDate>Mon, 10 Aug 2009 16:00:01 EST</pubDate>
	 <guid isPermaLink="false">news169136061</guid>
</item>
<item>
     <title>Critical link in cell death pathway revealed</title>
   	 <description>The role of a protein called XIAP in the regulation of cell death has been identified by Walter and Eliza Hall Institute researchers and has led them to recommend caution when drugs called IAP inhibitors are used to treat cancer patients with underlying liver conditions.</description>
     <link>http://www.physorg.com/news167488280.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 22 Jul 2009 13:31:52 EST</pubDate>
	 <guid isPermaLink="false">news167488280</guid>
</item>
<item>
     <title>Researchers identify genes linked to chemoresistance</title>
   	 <description>Two genes may contribute to chemotherapy resistance in drugs like 5-fluorouracil, which is used in liver cancer treatment, according to Virginia Commonwealth University Massey Cancer Center researchers.</description>
     <link>http://www.physorg.com/news167325348.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 20 Jul 2009 16:16:45 EST</pubDate>
	 <guid isPermaLink="false">news167325348</guid>
</item>
<item>
     <title>Gene's novel role may provide key to treating liver and neurodegenerative diseases</title>
   	 <description>Scientists at Singapore's Bioprocessing Technology Institute (BTI) have made a novel discovery about how the gene, "Fas-apoptosis inhibitory molecule" (FAIM), protects both immune and liver cells from apoptosis, or programmed cell death.</description>
     <link>http://www.physorg.com/news165825938.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 03 Jul 2009 07:46:05 EST</pubDate>
	 <guid isPermaLink="false">news165825938</guid>
</item>
<item>
     <title>Researchers engineer metabolic pathway in mice to prevent diet-induced obesity</title>
   	 <description>In recent years, obesity has taken on epidemic proportions in developed nations, contributing significantly to major medical problems, early death and rising health care costs. According to Centers for Disease Control and Prevention estimates, at least a quarter of all American adults and more than 15 percent of children and adolescents are obese.</description>
     <link>http://www.physorg.com/news163165465.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 02 Jun 2009 12:45:29 EST</pubDate>
	 <guid isPermaLink="false">news163165465</guid>
</item>
<item>
     <title>Old stain in a new combination</title>
   	 <description>New combinations of agents based on the oldest synthetic malaria drug, the methylene blue stain, can curb the spread of malaria parasites and make a significant contribution to the long-term eradication called for by the international "Roll Back Malaria Initiative." In a study on 160 children with malaria in Burkina Faso, specialists in tropical medicine from the Heidelberg University Hospital have shown that in combination with newer malaria drugs, methylene blue prevents the malaria pathogen in infected persons from being re-ingested by mosquitoes and then transmitted to others and is thus twice as effective as the standard therapy. The results of the study were published in May 2009 in the online journal PLoS One.</description>
     <link>http://www.physorg.com/news162034412.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 20 May 2009 10:33:57 EST</pubDate>
	 <guid isPermaLink="false">news162034412</guid>
</item>
<item>
     <title>Old diabetes drug teaches experts new tricks</title>
   	 <description>Research from the Johns Hopkins Children's Center reveals that the drug most commonly used in type 2 diabetics who don't need insulin works on a much more basic level than once thought, treating persistently elevated blood sugar  - the hallmark of type 2 diabetes  - by regulating the genes that control its production.</description>
     <link>http://www.physorg.com/news161527158.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 14 May 2009 13:39:55 EST</pubDate>
	 <guid isPermaLink="false">news161527158</guid>
</item>
<item>
     <title>Model tissue system reveals cellular communication via amino acids</title>
   	 <description>A team of researchers from the Massachusetts General Hospital Center for Engineering in Medicine (MGH-CEM) has found the first evidence of cell-to-cell communication by amino acids, the building blocks of proteins, rather than by known protein signaling agents such as growth factors or cytokines.  Their report will appear in an upcoming issue of the FASEB Journal and has been released online.</description>
     <link>http://www.physorg.com/news157987616.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 03 Apr 2009 14:27:18 EST</pubDate>
	 <guid isPermaLink="false">news157987616</guid>
</item>
<item>
     <title>Stem cells crucial to diabetes cure in mice</title>
   	 <description>More than five years ago, Dr. Lawrence C.B. Chan and colleagues in his Baylor College of Medicine laboratory cured mice with type 1 diabetes by using a gene to induce liver cells to make insulin.</description>
     <link>http://www.physorg.com/news156432110.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 16 Mar 2009 14:22:31 EST</pubDate>
	 <guid isPermaLink="false">news156432110</guid>
</item>
<item>
     <title>Suppressing cancer with a master control gene</title>
   	 <description>Starting with the tiny fruit fly and then moving into mice and humans, researchers at VIB and K. U. Leuven show that expression of the same gene suppresses cancer in all three organisms. Reciprocally, switching off the gene - called Ato in flies and ATOH1 in mammals - leads to cancer. The authors show there is a good chance that the gene can be switched on again with a drug. They report their findings in two papers in the leading online open access journal PLoS Biology.</description>
     <link>http://www.physorg.com/news154618409.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 23 Feb 2009 13:33:57 EST</pubDate>
	 <guid isPermaLink="false">news154618409</guid>
</item>
<item>
     <title>Discovery could lead to a new animal model for hepatitis C</title>
   	 <description>During its career, the potentially fatal hepatitis C virus has banked its success on a rather unusual strategy: its limitations. Its inability to infect animals other than humans and chimpanzees has severely hampered scientists in developing a useful small animal model for the disease. But now, in a breakthrough to be published in the January 29 advance online issue of Nature, Rockefeller University scientists have identified a protein that allows the virus to enter mouse cells, a finding that represents the clearest path yet for developing a much-needed vaccine as well as tailored treatments for the 170 million people across the globe living with the tenacious, insidious and rapidly changing virus.</description>
     <link>http://www.physorg.com/news152386635.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 28 Jan 2009 17:37:48 EST</pubDate>
	 <guid isPermaLink="false">news152386635</guid>
</item>
<item>
     <title>Building the right cells</title>
   	 <description>Just after 5 p.m. doors rattle shut and feet begin to shuffle past the narrow lab where Karim Si-Tayeb sits hunched over a microscope, all but invisible to the scientists leaving the Medical College of Wisconsin. Si-Tayeb has already worked eight hours and will work five more, eyes locked on the living cells in his care. Under the microscope, their tiny colonies resemble constellations of tightly packed stars. They carry his ambition.</description>
     <link>http://www.physorg.com/news150295895.html</link>
	 <category>Biology</category>
	 <pubDate>Sun, 04 Jan 2009 12:51:35 EST</pubDate>
	 <guid isPermaLink="false">news150295895</guid>
</item>
<item>
     <title>Stem cells with potential to regenerate injured liver tissue identified</title>
   	 <description>A novel protein marker has been found that identifies rare adult liver stem cells, whose ability to regenerate injured liver tissue has the potential for cell-replacement therapy. For the first time, researchers at the University of Pennsylvania School of Medicine led by Linda Greenbaum, MD, Assistant Professor of Medicine in the Division of Gastroenterology, have demonstrated that cells expressing the marker can differentiate into both liver cells and cells that line the bile duct.</description>
     <link>http://www.physorg.com/news145708384.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 12 Nov 2008 10:33:04 EST</pubDate>
	 <guid isPermaLink="false">news145708384</guid>
</item>
<item>
     <title>Senescence in liver cells can provoke a beneficial immune reaction</title>
   	 <description>Although post-reproductive life in humans is often associated with decline and a loss of powers, an analogous state in certain cells -- called senescence -- is proving to be one of ironic potency.  Scientists at Cold Spring Harbor Laboratory (CSHL) today reported that a particular class of senescent liver cells orchestrates a sequence of events in living mice that can limit fibrosis, a natural response of the liver to acute damage.</description>
     <link>http://www.physorg.com/news138541727.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 21 Aug 2008 12:48:47 EST</pubDate>
	 <guid isPermaLink="false">news138541727</guid>
</item>
<item>
     <title>To protect against liver disease, body puts cells 'under arrest'</title>
   	 <description>A stable form of cell-cycle arrest known to offer potent protection against cancer also limits liver fibrosis, a condition characterized by an excess of fibrous tissue, according to a new report in the August 22nd Cell, a Cell Press publication. Triggered by chronic liver damage produced by hepatitis infection, alcohol abuse, or fatty liver disease, liver fibrosis can lead to cirrhosis, a major health problem worldwide and the 12th most common cause of death in the United States.</description>
     <link>http://www.physorg.com/news138541591.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 21 Aug 2008 12:46:31 EST</pubDate>
	 <guid isPermaLink="false">news138541591</guid>
</item>
<item>
     <title>Researchers find a new role for a 'Foxy Old Gene'</title>
   	 <description>Researchers at the University of Pennsylvania School of Medicine have discovered that a protein called FOXA2 controls genes that maintain the proper level of bile in the liver. FOXA2 may become the focus for new therapies to treat diseases that involve the regulation of bile salts. The study was published online this week in Nature Medicine.</description>
     <link>http://www.physorg.com/news136808930.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 01 Aug 2008 11:28:50 EST</pubDate>
	 <guid isPermaLink="false">news136808930</guid>
</item>


</channel>
</rss>

